Skip to main content

Table 2 Costs (SEK) of health care and treatments before and after starting the insulin treatment

From: Total costs of basal or premixed insulin treatment in 5077 insulin-naïve type 2 diabetes patients: register-based observational study in clinical practice

  Pre-index Post-index Increment Net cost effect
  Health care Treatment Health care Treatment Health care Treatment
Treatment Mean/Median Mean/Median Mean/Median Mean/Median Mean/Median Mean/Median Mean/Median
NPH 19,674/3,228 2,455/1,587 16,570/3,240 8,191/6,840 −3,104/0 5,736/4,528 2,632/4,528
IG 22,861/3,457 2,857/1,959 19,746/3,143 10,818/9,343 −3,115/0 7,962/6,551 4,847/6,551
ID 9,544/2,458 3,041/1,608 11,402/2,647 12,351/10,706 1,858/0 9,310/7,690 11,168/7,690
PM 30,990/4,806 2,155/1,430 22,441/3,681 8,617/7,877 −8,549/-265 6,462/5,972 −2,087/5,707
p-values <0.0001 <0.0001 0.0001 <0.0001 0.0011 <0.0001  
  1. NPH Neutral protamine Hagedorn, IG insulin glargine, ID insulin determir, PM premixed insulin, SD standard deviation. The approximate value of 100 SEK is currently 12 US dollars (August 2015)